Phase I clinical trial of ifosfamide, oxaliplatin, and etoposide (IOE) in pediatric patients with refractory solid tumors
about
Phase I clinical trial of ifosfamide, oxaliplatin, and etoposide (IOE) in pediatric patients with refractory solid tumors
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
Phase I clinical trial of ifos ...... s with refractory solid tumors
@ast
Phase I clinical trial of ifos ...... s with refractory solid tumors
@en
Phase I clinical trial of ifos ...... s with refractory solid tumors
@nl
type
label
Phase I clinical trial of ifos ...... s with refractory solid tumors
@ast
Phase I clinical trial of ifos ...... s with refractory solid tumors
@en
Phase I clinical trial of ifos ...... s with refractory solid tumors
@nl
prefLabel
Phase I clinical trial of ifos ...... s with refractory solid tumors
@ast
Phase I clinical trial of ifos ...... s with refractory solid tumors
@en
Phase I clinical trial of ifos ...... s with refractory solid tumors
@nl
P2093
P2860
P1476
Phase I clinical trial of ifos ...... s with refractory solid tumors
@en
P2093
Chong Wang
Jianrong Wu
Lisa M McGregor
Sheri L Spunt
Victor M Santana
Wayne L Furman
P2860
P356
10.1097/MPH.0000000000000186
P577
2015-01-01T00:00:00Z